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mothers, children and the society at large.
BRIEF OVERVIEW OF THE REGULATORY 
PROCESS
Regulation of drugs and other regulated products 
entails public policies that control private behaviour 
for public good. Effective regulation ensures that 
only safe, efficacious and right quality products are 
used in Nigeria. Without aggressive strengthening 
of our regulatory activities, fake and substandard 
product eradication will not be sustained.
This is what we experienced prior to April 2001 
when I assumed office as Chief Executive Officer 
(CEO) of NAFDAC. We were faced with the 
arduous task of reactivating a failed food and drug 
regulatory environment of over three decades, 
which resulted in a crises situation characterized by 
massive copying of original brands of most 
regulated products. Various forms of fake drugs, 
unwholesome food, substandard cosmetics, 
chemicals and related products were dumped in 
Nigeria. The most worrisome was the case of tins of 
baby milk filled with a mixture of cassava flour and 
sugar.
The consequences of fake and counterfeit drugs 
were of greater dimension for obvious reasons and 
Nigeria became rated as one of the countries with 
the highest incidence of fake drugs.
The average incidence of counterfeit medicines in 
Nigeria was over 41% from various studies done 
before 2001. NAFDAC baseline study also showed 
that during the same period, about 68% of drugs in 
circulation were unregistered. Almost all drugs have 
been counterfeited, and counterfeiters target cost 
and volume. 
Fake drugs embarrassed our health care providers 
and eroded the confidence of the public in our 
healthcare system. It led to treatment failures, 
development of drug resistance and death. 
As people were dying, legitimate businesses were 
collapsing. Many multinational companies left 
INTRODUCTION
This dialogue has come at a very good time as a step 
towards achieving the target of the Millennium 
Development Goals (MDGs), which affects child 
mortality and maternal health by 2015. To achieve 
this, we need Public Private Partnership and all 
hands must be on deck; government, private sector, 
researchers, policy makers, NGOs, Religious 
Organizations and the society at large. Nigeria has 
been reported to have the worst under 5 mortality 
rate in Africa, ranging from 235 to 198 per 1000 live 
births in 1990 to 2003, respectively and high 
neonatal mortality rate of 48 per 1000 live births.
Some causes of neonatal mortality can be attributed 
to malaria, infections, acute respiratory tract 
infections, vaccine preventable diseases, etc. 
Malaria is a known cause of morbidity in-utero 
resulting in low birth weights with attendant 
lowered survival rates. Malaria also causes Preterm 
births. Also an estimated 50,000 Nigerian women 
die each year from complications in pregnancy and 
child birth, accounting for 10% of global estimates 
of maternal deaths. Some causes of these deaths are 
as a result of Malaria (11%), Anaemia (11%), 
Haemorrhage (23%), Eclampsia (11%), Sepsis 
(17%).
The Federal Government has made several efforts to 
reduce maternal and infant mortality and morbidity 
in Nigeria through various policies and 
establishment of various Agencies.  In line with this, 
the National Agency For Food and Drug 
Administration and Control (NAFDAC), 
established by Decree No. 15 of 1993 (as amended 
by Decree 19 of 1999), regulates and controls the 
manufacture, importation, exportation, distribution, 
advertisement sale and use of food, drugs, medical 
devices, chemicals, cosmetics, and packaged water 
(referred to as NAFDAC regulated products). 
The effective discharge of this mandate by 
NAFDAC, ensures essential drugs and other 
regulated products of good quality, efficacy and 
safety are available and easily accessible for 
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·Sophistication in Copying Technology
Sophistication in product faking has made it 
difficult for even brand owners to tell the 
difference between their brands and 
counterfeits. 
·False Declaration By Importers 
Some counterfeit product importers make false 
declarations about the contents of their 
containers. They stash drugs in the inner parts of 
containers of other items like clothes, motor 
spare parts and household items. We have made 
seizures of drugs concealed inside children's 
wears, men's clothes, duvets, shoes and DVD 
player cartoons.
·Inadequate Legislation
In most countries, laws against drug 
counterfeiting are very weak. Consequently, 
criminals are shifting from gun running and 
cocaine pushing to drug counterfeiting 
because it is financially as lucrative but of 
relatively lower risk. The penalties for 
producing, importing or distributing fake drugs 
or other fake regulated products in Nigeria range 
from imprisonment of 3 months to 5 years, or 
option of fine of N10,000 to N500,000. In order 
to stem this tide, the Agency reviewed the laws 
and forwarded to the National Assembly in 
2001, and we have resubmitted the reviewed 
laws several times on the legislators' request. We 
are still praying and waiting. The weak laws are 
further hampered by Abuse of Judicial Process, 
granting of inordinate injunctions to 
counterfeiters, long delays of trials and other 
handicaps.
i. Some cases get so protracted that the judges 
are either transferred or die in the process, and 
the cases are started all over again.
ii.On one occasion, a lawyer contracted by 
NAFDAC to prosecute a high profile case 
claimed that he lost all documents used in 
prosecuting the case.
iii. On another occasion, our lawyer (a 
Senior Advocate of Nigeria) signed to settle 
out of court with the defendant's lawyer 
without our permission.
·Lack of Awareness
Drugs counterfeiters succeeded for about three 
decades in Nigeria largely because of lack of 
awareness which was worsened by the culture of 
silence that enshrouds the issue of drug and 
other regulated products counterfeiting. People 
died inexplicably after the right diagnosis and 
Nigeria or divested out of frustration due to unfair 
competition with the counterfeiters. Made-in-
Nigeria drugs were banned by other West African 
countries.
CHALLENGES OF DRUG REGUALTION IN 
NIGERIA
The challenges of drug regulation encompass the 
totality of effective control and regulation of drugs, 
their production processes, all the personnel 
involved with them, as well as the consumers and 
general public.  
Factors which militate against effective drug 
regulation in Nigeria include;
·Corruption and Conflict of Interest/Insecure 
and Unfriendly Environment 
The drug counterfeiters came in different guises 
to negotiate with us so as to compromise us and 
continue to do their business as usual. When this 
failed they fought back with intimidation, 
harassment, blackmail and threats. On several 
occasions they deposited fetish objects in my 
office. When all of these failed, they resorted 
to physical attacks and arson against 
NAFDAC staff and facilities. These attacks 
culminated in a shooting attack on my person on 
December 26, 2003. During this near-death 
encounter, bullets shattered the back windscreen 
of my car, pierced through my head scarf and 
burnt my scalp. A bus driver was killed on the 
spot. Three months later, between 7th and 
11th March 2004, there was a synchronized 
burning of NAFDAC's facilities across the 
country. We also recorded twenty three other 
attacks against NAFDAC staff and 
destruction of over eight cars in the last seven 
years.
·Discriminatory Regulation by Exporting 
Countries
Some countries have strong regulations for 
drugs and other products consumed 
internally and little or no regulation for those 
meant for export, and this encourages 
exportation of fake products. This is critical 
since about 60% of drugs in Nigeria are 
imported. Most of the fake drugs in Nigeria 
are imported from India and China. 
Consequently, from 2001 till date, we have 
banned 30 Indian and Chinese companies 
and 1 Pakistani company, confirmed to be 
fake drug producers, from exporting drugs to 
Nigeria.
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NAFDAC staff for better effectiveness:  
·Corrupt, redundant and incorrigible staff 
were retrenched.
·New staff were employed based on merit.
·We embarked on staff training and re-
training, locally and internationally.
·There was effective delegation of duties and 
staff empowerment at all levels.
·There was constant staff performance 
evaluation to ensure commitment and 
effectiveness.
·Various welfare packages including 
thirteenth month salary was initiated and is 
being sustained.
·Hard work is rewarded. Reward is in the 
form of recognition, commendation letter, 
promotion, oversea inspection or training.
·Staff members who catch defaulting 
companies or report any staff that 
compromises with defaulting companies are 
similarly rewarded.
·Corruption is severely sanctioned. Staff 
members involved in aiding or abetting 
defaulting companies are out rightly 
dismissed.
·Heroic activities are adequately rewarded.
·Leadership by example is highly 
emphasized.
Restructuring and Modernizing the Regulatory 
Processes
NAFDAC was reorganized into eight functional 
Directorates as against the previous six. New 
directorates of Enforcement and Ports Inspection 
were established. We also established new state 
offices to cover the 36 states of Nigeria and the 
Federal Capital Territory Abuja. Six Zonal Offices 
and four special inspectorate offices were also 
established in towns with big drug markets. Five old 
laboratories were upgraded, three new ones are 
almost completed while warehouses and land 
border offices were also constructed. New Standard 
Operating Procedures and guidelines were 
developed so as to institutionalize our processes. All 
our regulatory processes are continuously upgraded 
and automated.
Public Enlightenment Campaigns
Enlightenment campaign remains one of our most 
effective strategies in combating product 
counterfeiting and creating effective regulation. 
Our enlightenment programme involves dialogue, 
correct medication were given without being 
able to link the deaths to fake drugs.
·Chaotic Drug Distribution System
Drug distribution in Nigeria is very chaotic, 
with drugs sold in open markets, in buses and 
ferries, and hawked in the streets.
·Lack of Cooperation Among Regulatory 
Agencies
Lack of cooperation among government 
regulatory and enforcement agencies (Food and 
Drug Agency, Customs, police, clearing agents, 
etc) at the ports creates a fertile ground for 
counterfeiting to thrive.
·Poor Database on Health Related Activities
Another factor that encourages faking of drugs 
and other regulated   products in Nigeria is the 
generally poor or total lack of record keeping, of 
health related activities in our various health 
establishments. There is actually no 
documentation or database on drugs used 
previously and experiences gained from using 
them.
·Irrational Use of Drugs
Equally critical is the issue of rational use of 
drugs, which concerns every member of the 
health care delivery team as well as the 
consumer.  The effect of dispensing doctors, 
prescribing nurses and some other health 
professionals becomes worrisome from this 
WHO report, “Many prescribers, as well as drug 
retailers, earn their living by selling medicines 
and not by charging consultation fees.  It has 
been shown in many countries that prescribers 
who earn money from dispensing medicines 
consistently prescribed more drugs than those 
who do not make money from dispensing.  In a 
study in Zimbabwe, dispensing doctors 
prescribed antibiotics to 58% of their patients 
compared to non-dispensing doctors who 
prescribed antibiotics to 48% of their patients”.   
You can imagine the consequence on pregnant 
mothers and neonates.  
NAFDAC STRATEGIES TO ENSURE 
EFFECTIVE REGULATION OF DRUGS IN 
NIGERIA
Staff Re-orientation, Reorganization and 
Motivation.
The following measures were taken to reposition 
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other regulated products before they can be 
exported to Nigeria.
·NAFDAC requires mandatory pre-shipment 
information to be provided by all importers 
before the arrival of their drugs.
·NAFDAC's clearance permit is a requirement for 
Nigerian Banks to process any financial 
document for drug importers. 
·Before an imported drug, food or cosmetic is 
registered in Nigeria, we ensure that it is being 
used in the country of production by insisting on 
the provision of the Certificate of Free Sale, 
signed by the Minister of Trade or Industry in that 
country, and authenticated by the Nigerian 
Embassy, or any Commonwealth Mission if 
there is no Nigerian Embassy in that country. 
Beefing Up of Surveillance at All Ports of Entry
·NAFDAC has re-enforced the Directorates of 
Ports Inspection and Enforcement, for more 
effective surveillance at all ports of entry and 
better enforcement activities. 
·NAFDAC also stepped up surveillance at both 
land and sea borders, which led to the 
counterfeiters resorting to the use of airlines. 
Consequently, NAFDAC issued a guideline 
that any aircraft that lifts drugs to Nigeria 
without obtaining NAFDAC's authorization 
from their clients would be grounded.
Mopping Up Fake Drugs and Other 
Substandard Regulated Products already in 
Circulation 
·Cognizant of our many porous borders, 
NAFDAC embarked on planned, continuous and 
sustained surveillance at all markets and retail 
outlets for drugs and other regulated products.
·We carry out routine sampling, checking and 
testing of all NAFDAC registered products in 
circulation.
·We also trace fake drug and other regulated 
product dealers through reports from victims, 
health professionals and constant tip-off from the 
public.
·Reports made by individuals have enabled us to 
trace the source of large consignments of fake 
drugs and other substandard regulated products.
·In 2003, Nigerian journalists reported the 
death of three children after an open-heart 
surgery. NAFDAC's investigations confirmed 
that fake drugs were used during the surgery. 
·In 2004, following reports from doctors about 
education and persuasion because this addresses the 
fundamenta l  i s sue  a t  s t ake ,  which  i s  
BEHAVIOURAL CHANGE. 
These campaigns are sustained by using:
· Print and electronic media, jingles, alert 
notices, billboards and publications on the 
differences between identified fake 
and genuine products.
· We also produced many other 
publications in English and Vernacular.
· Workshops, seminars and meetings 
have been conducted for most stakeholders.
· Mobilization campaigns for rural 
dwellers are on-going.
·In 2002, NAFDAC instituted an annual essay 
competition for Nigerian High School children 
for which cash prizes are given to the winners 
and computers, television sets, microscopes 
and encyclopedia are given to their schools at 
State, Zonal and National levels. We also 
established Consumer Safety Clubs in these 
schools as a platform for interacting with and 
educating the students for the establishment of 
a culture of quality consciousness in Nigeria. 
·In May 2007, NAFDAC Green Pages, a 
comprehensive multi-media publication that 
contains particulars of all NAFDAC registered 
products was launched. This publication 
includes names of products, NAFDAC 
registration numbers, names and addresses of 
manufacturers, importers and local agents.
·NAFDAC is  cur ren t ly  working  in  
collaboration with NYSC members posted to 
the Agency in all States of the federation to 
carry and disseminate information on 
NAFDAC activities to all the villages and 
local government areas in the country. We have 
successfully completed this in Abuja, Lagos, 
Port Harcourt and Ibadan and other states will 
follow.
Stopping the Importation of Fake Drugs and 
Other Substandard Regulated Products to 
Nigeria at Source i.e. Countries of Production
·NAFDAC officials must inspect factories 
anywhere in the world before we register their 
drugs, food and other NAFDAC regulated 
products, to ensure compliance with current 
Good Manufacturing Practice (cGMP).
·NAFDAC appointed independent analysts in 
India, China and Egypt who re-certify drugs and 
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which include the following:
·All products must comply with inspection 
requirements and laboratory standards before 
they are registered.
·Renewal of registration of drugs and other 
regulated products is every 5 years, while 
renewal of herbal medicine listing is done every 
2 years until the product gets full registration. For 
herbal medicine we test only for quality and 
safety as is done all over the world with this 
caveat on the label, “These claims have not been 
evaluated by NAFDAC”.
·NAFDAC insists on fixing of NAFDAC 
REGISTRATION NUMBER on the label of all 
products to enable the public identify registered 
products. 
·NAFDAC will soon commence the use of 
serialized holographic labels to safeguard 
NAFDAC registration numbers on registered 
products to prevent counterfeiters from 
copying and faking NAFDAC numbers. 
·Drugs can be imported for a maximum of ten 
years, after which the importer must start local 
production.
Regulation and Control of Clinical Trials
Clinical trial is a requirement for NAFDAC 
registration of new drug molecules in Nigeria. 
NAFDAC ensures that clinical trials are conducted 
in compliance with regulatory requirements. In this 
regards, we have established a Clinical Trial Unit in 
the Registration and Regulatory Affairs Directorate 
and developed all necessary regulations and 
guidelines for clinical trials of drugs. 
OTHER INTERVENTIONS:
·P h a r m a c o v i g i l a n c e :  N A F D A C  
established a National Pharmacovigilance 
Centre (NPC) in September 2004 and we got 
admitted as the 74th member of the WHO Drug 
Safety Monitoring Program. Till date, we have 
received over 649 reports of adverse drug 
reactions. These reports have enabled us to ban 
or restrict the use of some drugs.
·Regulatory control of prescription 
medicines: It is common practice in Nigeria for 
ethical drugs to be purchased without 
prescription. This fuels irrational drug use 
which sustains drug counterfeiting. NAFDAC 
has started enforcing the requirement that 
ethical drugs are obtained strictly on 
adverse reactions of some infusions on their 
patients, infusions were sampled from all over 
the country, and our results confirmed that 
some batches of infusions produced by 4 
indicted companies were contaminated with 
microorganisms. 
·In the same year, 147 of the 149 brands of 
water for injection screened on routine 
sampling were found to be non- sterile.
·Raids are regularly carried out on drug hawkers, 
and their drugs are confiscated and destroyed.
·This continuous surveillance has led to the 
sealing off of drug shops, supermarkets and 
eateries, and the closure of 3 major drug markets: 
Aba for 6 months in 2002, Kano for 3 months in 
2004 and Onitsha for almost 4 months in 2007.  
·To achieve a high level of success with our 
mopping up exercise, NAFDAC has put in place 
the following guidelines: 
- We confiscate and subsequently 
destroy all drugs from sellers who fail 
to provide proper invoices of purchase 
with full names and addresses. This is 
to enable us trace the big time importers, 
producers and distributors of fake drugs.
- Faced with the frustrations of 
evacuating many lorry loads of fake 
drugs from warehouses on tip off 
without anybody accepting ownership, 
NAFDAC notified the public that 
whenever the importer of fake drugs 
cannot be traced, the landlord of the 
premises used for the storage of such 
products would be arrested, with a 
view to tracing the importer. On one 
occasion in Lagos, it was only after the 
landlord of the warehouse was arrested 
that the fake drug owner surfaced.
R e g u l a r  G M P M o n i t o r i n g  o f  L o c a l  
Manufacturers
·NAFDAC monitors local manufacturers of drugs 
and other regulated products routinely to ensure 
compliance with Good Manufacturing Practice. 
·Compliance Directives are issued and enforced 
to the letter when lapses are observed. 
·Prosecution is carried out as a last resort. 
Streamlining and Strict Enforcement of our 
Registration Guidelines 
NAFDAC has strengthened its registration 
processes with some administrative guidelines 
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longer a dumping ground for fake products. 
·Counterfeit drugs in circulation have dropped 
from an average of over 41% in 2001 to 16.7% 
in 2006. 
·Drugs unregistered by NAFDAC stood at 19% 
in 2006 as against 68% recorded in 2001.
·The production capacities of our local 
pharmaceutical industries have increased 
tremendously, and their number has risen from 
70 to 150 in the last 7 years. 
·By 2001 our local pharmaceutical industries 
were producing less than 25% of our drug need, 
but now they produce over 40%. 
·There is a continuous upward movement in the 
share prices of the pharmaceutical companies 
quoted in the Nigerian Stock Exchange.  
·Many multinational pharmaceutical companies 
are coming back to Nigeria as a result of the 
improved regulatory environment. 
·Ban on 'made-in-Nigeria' drugs has been lifted 
by other West African countries. In fact there is 
so much confidence in 'made-in-Nigeria' drugs 
that our drugs are now marketed in many 
African countries.  At the ports, we have even 
intercepted drugs made in India but labeled 
'made-in-Nigeria'. 
·In the last 7 years, NAFDAC has carried out 
121 destruction exercises of counterfeit and 
substandard products valued at over 22.8 
Billion Naira.
·45 convictions have been secured in respect of 
counterfeit drug related cases, while 60 cases 
are pending in courts. 
·Old food and cosmetics industries are 
expanding their production capacities while 
new ones are springing up.
·Sanitization of bottled and sachet water 
production has greatly reduced cholera and 
other water-borne disease outbreaks, which 
used to be rampant in the country. 
·NAFDAC monitors salt iodization, and 
UNICEF has rated Nigeria as the first country 
in Africa to achieve Universal Salt Iodization 
(USI). We are currently working to achieve the 
same feat with Vitamin A fortification.
·The use of bromate by Nigerian bakers has 
dropped from over 95% in 2001 to less than 
0.001% in 2007.
These 'Short-term-wins' have become great morale 
boosters for the NAFDAC team. They have earned 
us the respect of consumers and regulated 
industries, as well as the trust, support and political 
prescription. In agreement with other 
stakeholders, we started with all injectables 
in addition to sedatives that are already 
being enforced. Others will follow in phases.
·International Collaboration: NAFDAC 
initiated and is currently heading the West 
African Drug Regulatory Authorities 
Network (WADRAN) which is a forum 
where heads of drug regulatory authorities 
in West Africa can share strategies and 
experiences and carry one another along in 
the fight against drug counterfeiters.
This was necessitated by the fact that when 
drug counterfeiters were chased out of Nigeria, 
they relocated to other West African countries 
and became a big problem for them. It therefore 
became necessary for us to work in concert so 
as to ensure that drug counterfeiters do not find 
a safe haven anywhere in the sub-region. We 
are also extending this collaboration to other 
countries in Africa. 
·In 2002, we proposed and have continued to 
advocate for the establishment of an 
international convention on counterfeit 
drugs, just as we have for narcotics and 
psychotropic substances. In 2006, WHO 
proposed the international Medicine 
Products Anti-counterfeiting Taskforce 
(IMPACT), which was subsequently 
established to formulate and execute 
strategies for international collaboration. 
NAFDAC is also playing a leading role in 
IMPACT by virtue of my being the Vice 
Chair.
C E L E B R A T I N G  S H O R T  T E R M  
MILESTONES
Although we have not reached our final destination, 
we can celebrate the following milestones:
·We have sanitized the food and drug industry, 
and created a reasonably well regulated 
environment that have saved the lives of 
millions of Nigerians, and indeed millions of 
Africans and boosted our economy by 
encouraging local industries and foreign 
investors. 
·Immense public awareness has resulted in the 
participation of all stakeholders in the 
regulatory processes, and this has awakened 
international consciousness that Nigeria is no 
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subsequent efficacy or toxicity.
o Ensuring that source of drugs for the 
Teaching Hospital, Health Centres and 
Private Clinics are from certified 
manufacturers or their  accredited 
distributors.  Increased patronage of locally 
m a n u f a c t u r e d  d r u g s  i s  s t r o n g l y  
recommended.
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CONCLUSION
Although drug regulation is basically a government 
function, effective food and drugs regulation 
requires the support and participation of all 
stakeholders including the consumers.
The regulated industry must take advantage of the 
established linkages and collaborations within the 
industry to encourage self-regulation. 
The reduction of maternal and infant deaths in 
Nigeria to the barest minimum requires the 
following strategies as regards drug regulation and 
control:
o Full support to the eradication of fake drugs 
and other unwholesome regulated products 
and creat ion of  a  well-regulated 
environment.  
o Encouragement of local capacity building in 
the drug manufacturing industry.
o Introduction of overt and covert security 
m e a s u r e s  b y  r e g u l a t e d  p r o d u c t  
manufacturers right from product design to 
secure their products from counterfeiting. 
o Teaching and practice of rational use of 
drugs and proper storage conditions should 
be given some focus in the medical and 
pharmacy schools as well as in the 
professional practice environment. Drug 
storage and cold chain maintenance of 
vaccines are critical to drug integrity and 
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